slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
5.900 KRW | -0,51% | -0,17% | -4,68% |
22/12 | Jin Yang Pharmaceutical Co. Ltd.'s Aandeleninkoopplan verlengd tot 22 december 2024. | CI |
17/11 | Het aandeleninkoopplan van Jin Yang Pharmaceutical Co., Ltd. verlengd tot 18 november 2024. | CI |
Omzet 2022 | 76,26 mld. 56,51 mln. 52,39 mln. | Omzet 2023 | 94,11 mld. 69,74 mln. 64,65 mln. | Marktkapitalisatie | 66,81 mld. 49,5 mln. 45,9 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | 12,31 mld. 9,12 mln. 8,46 mln. | Nettowinst (verlies) 2023 | 12,66 mld. 9,38 mln. 8,7 mln. | EV/omzet 2022 | 1,05 x |
Nettoschuld 2022 | 9,49 mld. 7,03 mln. 6,52 mln. | Nettoschuld 2023 | 4,34 mld. 3,22 mln. 2,98 mln. | EV/omzet 2023 | 0,76 x |
K/w-verhouding 2022 |
6,61
x | K/w-verhouding 2023 |
5,27
x | Werknemers | 220 |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 59,84% |
1 dag | -0,51% | ||
1 week | -0,17% | ||
Lopende maand | -0,84% | ||
1 maand | -1,17% | ||
3 maanden | -4,53% | ||
6 maanden | -1,99% | ||
Lopend jaar | -4,68% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Jae-Jun Choi
CEO | Chief Executive Officer | 54 | - |
Yoon-Hwan Choi
CHM | Chairman | 87 | - |
Jong-Gu Im
BRD | Director/Board Member | 66 | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Yoon-Hwan Choi
CHM | Chairman | 87 | - |
Jae-Jun Choi
CEO | Chief Executive Officer | 54 | - |
Jong-Gu Im
BRD | Director/Board Member | 66 | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
28-03-24 | 5.900 | -0,51% | 8 144 |
27-03-24 | 5.930 | -1,00% | 11 215 |
26-03-24 | 5.990 | 0,00% | 13 713 |
25-03-24 | 5.990 | +2,04% | 35 398 |
22-03-24 | 5.870 | -0,51% | 15 027 |
slotkoers Korea S.E., 28 maart 2024
Meer koersenVaira. 1 jan. | Kapi. | |
---|---|---|
-4,68% | 47,38 mln. | |
+28,67% | 46,19 mld. | |
+18,57% | 22,88 mld. | |
+20,11% | 14,18 mld. | |
+0,55% | 12,63 mld. | |
+46,16% | 12,07 mld. | |
-1,55% | 7,85 mld. | |
-0,05% | 6,79 mld. | |
-8,87% | 5,73 mld. | |
+7,37% | 5,14 mld. |